Shares of ProNAi Therapeutics Inc. (NASDAQ:DNAI) have been assigned an average broker rating score of 3.00 (Hold) from the three brokers that provide coverage for the stock, Zacks Investment Research reports. Three equities research analysts have rated the stock with a hold rating. ProNAi Therapeutics’ rating score has declined by 20% from 90 days ago […]
